Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study.

Holdaas H, Fellström B, Cole E, Nyberg G, Olsson AG, Pedersen TR, Madsen S, Grönhagen-Riska C, Neumayer HH, Maes B, Ambühl P, Hartmann A, Staffler B, Jardine AG; Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators.

Am J Transplant. 2005 Dec;5(12):2929-36. Erratum in: Am J Transplant. 2006 Aug;6(8):1986.

2.

Effect of fluvastatin on cardiac outcomes in kidney transplant patients with systemic lupus erythematosus: a randomized placebo-controlled study.

Norby GE, Holme I, Fellström B, Jardine A, Cole E, Abedini S, Holdaas H; Assessment of Lescol in Renal Transplantation Study Group.

Arthritis Rheum. 2009 Apr;60(4):1060-4. doi: 10.1002/art.24379.

3.

Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.

Alvarez-Sala LA, Cachofeiro V, Masana L, Suarez C, Pinilla B, Plana N, Trias F, Moreno MA, Gambus G, Lahera V, Pintó X.

Clin Ther. 2008 Jan;30(1):84-97. doi: 10.1016/j.linthera.2008.01.013.

PMID:
18343245
4.

Beneficial effect of early initiation of lipid-lowering therapy following renal transplantation.

Holdaas H, Fellström B, Jardine AG, Nyberg G, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Logan JO, Staffler B, Gimpelewicz C; ALERT Study Group.

Nephrol Dial Transplant. 2005 May;20(5):974-80. Epub 2005 Mar 22.

5.

No detrimental effect on renal function during long-term use of fluvastatin in renal transplant recipients in the Assessment of Lescol in Renal Transplantation (ALERT) study.

Fellström B, Abedini S, Holdaas H, Jardine AG, Staffler B, Gimpelewicz C; Assessment of Lescol in Renal Transplantation (ALERT) study group.

Clin Transplant. 2006 Nov-Dec;20(6):732-9.

PMID:
17100723
6.

fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: post-hoc subgroup analyses of the ALERT Study.

Jardine AG, Holdaas H, Fellström B, Cole E, Nyberg G, Grönhagen-Riska C, Madsen S, Neumayer HH, Maes B, Ambühl P, Olsson AG, Holme I, Fauchald P, Gimpelwicz C, Pedersen TR; ALERT Study Investigators.

Am J Transplant. 2004 Jun;4(6):988-95.

7.

Metabolic syndrome and cardiovascular risk in renal transplant recipients: effects of statin treatment.

Soveri I, Abedini S, Holdaas H, Jardine A, Eriksson N, Fellström B.

Clin Transplant. 2009 Nov-Dec;23(6):914-20. doi: 10.1111/j.1399-0012.2009.01025.x. Epub 2009 Jul 5.

PMID:
19594771
8.

Renal transplant dysfunction--importance quantified in comparison with traditional risk factors for cardiovascular disease and mortality.

Soveri I, Holdaas H, Jardine A, Gimpelewicz C, Staffler B, Fellström B.

Nephrol Dial Transplant. 2006 Aug;21(8):2282-9. Epub 2006 Mar 30.

PMID:
16574686
9.

Impact of fluvastatin on hyperlipidemia after renal transplantation.

Tokumoto T, Tanabe K, Ishida H, Shimmura H, Ishikawa N, Goya N, Akiba T, Toma H.

Transplant Proc. 2004 Sep;36(7):2141-4.

PMID:
15518777
10.

Fluvastatin reduces the impact of diabetes on long-term outcome after coronary intervention--a Lescol Intervention Prevention Study (LIPS) substudy.

Arampatzis CA, Goedhart D, Serruys PW, Saia F, Lemos PA, de Feyter P; LIPS Investigators.

Am Heart J. 2005 Feb;149(2):329-35.

PMID:
15846273
11.

Cardiovascular risk and renal transplantation: post hoc analyses of the Assessment of Lescol in Renal Transplantation (ALERT) Study.

Jardine AG, Fellström B, Logan JO, Cole E, Nyberg G, Grönhagen-Riska C, Madsen S, Neumayer HH, Maes B, Ambühl P, Olsson AG, Pedersen T, Holdaas H.

Am J Kidney Dis. 2005 Sep;46(3):529-36.

PMID:
16129216
12.

Efficacy and tolerability of fluvastatin XL 80 mg alone, ezetimibe alone, and the combination of fluvastatin XL 80 mg with ezetimibe in patients with a history of muscle-related side effects with other statins.

Stein EA, Ballantyne CM, Windler E, Sirnes PA, Sussekov A, Yigit Z, Seper C, Gimpelewicz CR.

Am J Cardiol. 2008 Feb 15;101(4):490-6. doi: 10.1016/j.amjcard.2007.09.099. Epub 2007 Dec 20.

PMID:
18312764
13.

Risk reduction and tolerability of fluvastatin in patients with the metabolic syndrome: a pooled analysis of thirty clinical trials.

Winkler K, Ablethauser CB, Gimpelewicz C, Bortolini M, Isaacsohn JL.

Clin Ther. 2007 Sep;29(9):1987-2000.

PMID:
18035198
14.

Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial.

Holdaas H, Fellström B, Jardine AG, Holme I, Nyberg G, Fauchald P, Grönhagen-Riska C, Madsen S, Neumayer HH, Cole E, Maes B, Ambühl P, Olsson AG, Hartmann A, Solbu DO, Pedersen TR; Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators.

Lancet. 2003 Jun 14;361(9374):2024-31.

PMID:
12814712
15.

Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV).

Dunkelgrun M, Boersma E, Schouten O, Koopman-van Gemert AW, van Poorten F, Bax JJ, Thomson IR, Poldermans D; Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group.

Ann Surg. 2009 Jun;249(6):921-6. doi: 10.1097/SLA.0b013e3181a77d00.

PMID:
19474688
16.
17.

Conversion to tacrolimus and atorvastatin in cyclosporine-treated heart transplant recipients with dyslipidemia refractory to fluvastatin.

Skalicka B, Kubanek M, Malek I, Vymetalova Y, Hoskova L, Podzimkova M, Kautzner J.

J Heart Lung Transplant. 2009 Jun;28(6):598-604. doi: 10.1016/j.healun.2009.03.014.

PMID:
19481021
18.

The effect of fluvastatin on cardiac outcomes in patients with moderate to severe renal insufficiency: a pooled analysis of double-blind, randomized trials.

Holdaas H, Wanner C, Abletshauser C, Gimpelewicz C, Isaacsohn J.

Int J Cardiol. 2007 Apr 12;117(1):64-74. Epub 2006 Aug 4. Review.

PMID:
16889855
19.

Fluvastatin treatment is not associated with an increased incidence of cancer.

Stein EA, Corsini A, Gimpelewicz CR, Bortolini M, Gil M.

Int J Clin Pract. 2006 Sep;60(9):1028-34. Review.

PMID:
16939542
20.

Cerebrovascular events in renal transplant recipients.

Abedini S, Holme I, Fellström B, Jardine A, Cole E, Maes B, Holdaas H; ALERT Study Group.

Transplantation. 2009 Jan 15;87(1):112-7. doi: 10.1097/TP.0b013e31818bfce8.

PMID:
19136900

Supplemental Content

Support Center